Description
P16 Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry
Article: P16 Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry
€3.03
Related products
-
Article: Highlights in gynaecological cancers
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Calendar of events
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart
